The company collects agricultural waste from farmers and processes it into biomass pellets and briquettes used as a renewable coal substitute for industrial boilers and power plants.
The company lacks a durable moat as it operates in a fragmented commodity industry with low barriers to entry. While high ROCE suggests efficiency, the razor-thin net margins (3.2%) and negative cash conversion indicate a lack of pricing power and heavy reliance on working capital cycles.
Earnings are primarily reinvested into expanding manufacturing capacity and R&D for torrefaction technology. While returns on capital are high, the company remains dependent on external equity and debt to fund its rapid growth and working capital needs.
The company's rapid revenue expansion proved to be a profitless mirage as the razor-thin 3.2% net margins were entirely consumed by rising logistics costs and working capital inefficiencies. Despite the massive growth in top-line sales, the negative cash conversion cycle forced the business into a debt spiral to fund inventory that the books and bank statements couldn't even agree on. As competition flooded the low-barrier biofuels market, the lack of pricing power turned the high ROCE into a historical footnote, leaving the company with idle manufacturing capacity and no cash to service its obligations.
RichFakir rates Shubhshree Biofuels Energy Ltd's business quality as mediocre — 44/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shubhshree Biofuels Energy Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shubhshree Biofuels Energy Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shubhshree Biofuels Energy Ltd's fair value is about ₹133 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →